Korea United Pharm. Inc.
Clinical trials sponsored by Korea United Pharm. Inc., explained in plain language.
A South Korean pharmaceutical company producing generic and specialty drugs.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
-
New combo pill for blood pressure and cholesterol moves to safety testing
Disease control Recruiting nowThis trial studies two experimental drugs, UIC202601 and UIC202602, designed to treat high blood pressure and high cholesterol. It enrolls healthy adults aged 19 to 55 to see how the drugs interact when taken together, focusing on safety and how the body processes them. Participa…
Phase: PHASE1 • Sponsor: Korea United Pharm. Inc. • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
New cholesterol combo drugs enter human testing
Knowledge-focused Recruiting nowThis early-stage trial is testing two experimental drugs for high cholesterol, called UIC202502 and UIC202505, in 50 healthy adults. The goal is to see how the drugs interact when taken together or alone, and to check for safety. Participants will take each drug separately and th…
Phase: PHASE1 • Sponsor: Korea United Pharm. Inc. • Aim: Knowledge-focused
Last updated Jun 26, 2026 14:33 UTC